Dietary supplements timed to migraine phases in adults with migraine
Tests phase-specific dietary supplements for quality of life and work in adults with migraine.
Plain-language title generated from the registry record
Registry title: Evaluation of the Migraceutics® Phase-Specific Dietary Supplement Regimen on Quality of Life, Work Productivity, and Biomarkers in Adult Migraineurs: The Migraceutics® START Study
Key facts
- Where
- Lutherville-Timonium, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT07634146, who can take part
Where in United States
- Natural MigraceuticalsLutherville-Timonium, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Miracle Wellness LLC
- Trial code
- NCT07634146
- Record updated
- 8 June 2026
- Original description
The purpose of this study is to evaluate the impact of the Migraceutics® phase-specific dietary supplement regimen on quality of life, work productivity, and biomarkers in adult migraineurs.Read full original descriptionShow less
A Randomized, Sham Supplement- and Care-as-Usual-Controlled Study to Evaluate Migraceutics® Phase-Specific Dietary Supplement Regimen on Quality of Life, Work Productivity, and Biomarkers in Adult Migraineurs: The Migraceutics® START Study
The purpose of this study is to evaluate the impact of the Migraceutics® phase-specific dietary supplement regimen on quality of life, work productivity, and biomarkers in adult migraineurs.
Inclusion: Self-reported history of migraine, based on the International Headache Society (IHS) International Classification of Headache Disorders, 3rd edition (ICHD-3) diagnostic criteria for migraine; Being able to take oral supplements; Agreeing to maintain their regular lifestyle; Access to internet and telephone.
Exclusion: Use of overlapping supplements or interacting medications; Daily use of alcohol, tobacco, or recreational drugs; Participation in any other clinical or interventional study within 30 days prior to baseline or concurrently; Presence of any active medical condition or diagnosis other than episodic migraine, including liver or kidney disease or condition; Known allergies to study ingredients; Pregnancy or lactation.